Boom-IBD Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions
IBD
Interventions
DEVICE

Neuromodulation

Neuromodulation

Trial Locations (8)

10029

The Mount Sinai Medical Center, New York

10032

Columbia University Irving Medical Center, New York

19104

University of Pennsylvania, Perelman School of Medicine Division of Colorectal Surgery, Philadelphia

80045

CU Anschutz, Aurora

89113

Las Vegas Medical Research, Las Vegas

90048

Phillip Fleshner, Inc., Los Angeles

94301

Palo Alto Medical Foundation Research Institute, Palo Alto

67226-8119

Kansas Gastroenterology, Wichita

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Boomerang Medical

INDUSTRY